Menu Back to DIA-Annual-Canadian-Meeting

Overview

The DIA Annual Canadian Meeting will deliver a comprehensive overview of the current bio-pharma and device landscape in Canada, while sharing insights into Canada’s broader role in global healthcare product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing and partnerships to key regulatory and clinical considerations for drugs and devices, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe.

Bringing together key stakeholders from the drug/device and Patient Self Care industries, regulatory agencies, and academia, this meeting will discuss and analyze the relevant challenges and opportunities for professionals working in the field in Canada.


Travel Once, Learn Twice!

Receive $150 off your registration fee when you register for the DIA Annual Canadian Meeting and the Canadian Advertising and Promotion Regulatory Affairs Conference or the DIA Annual Canadian Meeting and the Canadian Pharmacovigilance and Risk Management Conference!


Key Takeaways from the 2018 Meeting

  • Access to Health Canada Officials
  • CADTH Participation
  • Multi-stakeholder perspectives
  • Forward-looking sessions
  • Comprehensive discussions around R2D2

DIA Annual Canadian Meeting
Call for Abstracts

Abstract Submission Deadline: Friday, June 28

ReadAbstract Details | Submit


While we work to develop this year’s agenda check out our 2018 Program!


Program Committee

  • Marc F. Poitras, PhD, MBA
    Marc F. Poitras, PhD, MBA Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
    Health Canada, Canada
  • Lisa  Chartrand
    Lisa Chartrand Director, Regulatory Affairs and Quality Management
    Hoffmann-La Roche Limited, Canada
  • Loretta  Del Bosco
    Loretta Del Bosco Director, Regulatory Affairs Quality Assurance Operations
    AbbVie Corporation, Canada
  • Fiona  Frappier, PhD
    Fiona Frappier, PhD Senior Policy Analyst
    Health Canada, Canada
  • Lorella  Garofalo, PhD
    Lorella Garofalo, PhD Director, Regulatory Affairs; Worldwide Safety and Regulatory-Innovative
    Pfizer Canada Inc, Canada
  • Melissa  Hunt, MSc
    Melissa Hunt, MSc Acting Director
    Health Canada, Canada
  • Yatika  Kohli, PhD, MBA
    Yatika Kohli, PhD, MBA Executive Director - Global Regulatory Affairs
    NoNO Inc, Canada
  • Rania  Mouchantaf, PhD
    Rania Mouchantaf, PhD Manager
    Marketed Health Product Directorate, Health Canada, Canada
  • Kristin  Willemsen, MS
    Kristin Willemsen, MS Director of Scientific & Regulatory Affairs
    Consumer Health Products Canada, Canada
Load More

Contact us

Registration Questions?

Send Email
1.888.257.6457


DIA Annual Canadian Meeting
Call for Abstracts

Abstract Submission Deadline: Friday, June 28

Read Abstract Details | Submit

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download